Feature

Sen. Schumer backs federal decriminalization of marijuana


 

U.S. Sen. Chuck Schumer, the Senate majority leader, is cosponsoring legislation that would decriminalize marijuana at the federal level.

Marijuana leaves VladK213/Getty Images

The Cannabis Administration & Opportunity Act would allow the federal government to regulate and tax marijuana sales for the first time and would stop the federal prosecution of people for possessing and selling the drug, The New York Times reported. States could still make their own marijuana laws, however.

The bill calls for using money raised by taxing marijuana to help poor people and communities of color that have been unduly affected by marijuana laws.

Arrests and convictions for nonviolent marijuana offenses would be automatically expunged, The New York Times reported.

“The War on Drugs has been a war on people – particularly people of color,” a draft of the bill said, adding that the bill “aims to end the decades of harm inflicted on communities of color by removing cannabis from the federal list of controlled substances and empowering states to implement their own cannabis laws.”

But passage of the bill is highly uncertain because of strong Republican opposition in the Senate, where Democrats hold a narrow majority, according to The New York Times.

President Biden has not said he supports such legislation.

Sen. Schumer signaled his intentions when he spoke on April 20, the unofficial holiday for marijuana smokers.

“Hopefully, the next time this unofficial holiday of 4/20 rolls around, our country will have made progress in addressing the massive overcriminalization of marijuana in a meaningful and comprehensive way,” he said at the time, the newspaper reported.

Cosponsors were U.S. Sen. Cory Booker of New Jersey and U.S. Sen. Ron Wyden of Oregon, chairman of the Senate Finance Committee.

A version of this article first appeared on WebMD.com.

Recommended Reading

Pediatric cancer survivors at risk for opioid misuse
Federal Practitioner
Hypertension worsened by commonly used prescription meds
Federal Practitioner
Transcranial brain stimulation can modulate placebo and nocebo experiences
Federal Practitioner
Reduction of Opioid Use With Enhanced Recovery Program for Total Knee Arthroplasty
Federal Practitioner
Outcomes Associated With Pharmacist- Led Consult Service for Opioid Tapering and Pharmacotherapy
Federal Practitioner
Veteran and Provider Perspectives on Telehealth for Vocational Rehabilitation Services
Federal Practitioner
Physician convicted in buprenorphine scheme faces up to 20 years in prison
Federal Practitioner
Infusion centers may best EDs for treating sickle cell crises
Federal Practitioner
‘Long haul’ COVID recovery worse than cancer rehab for some: CDC
Federal Practitioner
A Pilot With Electrical Pain in the Face
Federal Practitioner